A detailed history of Israel Englander (Millennium Management LLC) transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Millennium Management LLC holds 20,000 shares of JAZZ stock, worth $2.53 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
20,000
Previous 450,872 95.56%
Holding current value
$2.53 Million
Previous $48.1 Million 95.37%
% of portfolio
0.0%
Previous 0.02%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$100.57 - $116.37 $20.2 Million - $23.4 Million
201,074 Added 44.6%
651,946 $72.7 Million
Q2 2024

Aug 14, 2024

BUY
$103.94 - $118.98 $44.4 Million - $50.8 Million
427,246 Added 1808.37%
450,872 $48.1 Million
Q1 2024

May 15, 2024

SELL
$115.19 - $132.77 $65.1 Million - $75 Million
-564,837 Reduced 95.99%
23,626 $2.85 Million
Q4 2023

Feb 14, 2024

BUY
$114.26 - $136.0 $2.76 Million - $3.29 Million
24,176 Added 4.28%
588,463 $72.4 Million
Q2 2023

Aug 14, 2023

SELL
$122.5 - $147.16 $77.3 Million - $92.9 Million
-631,294 Reduced 52.8%
564,287 $70 Million
Q1 2023

May 15, 2023

BUY
$133.98 - $160.47 $96.4 Million - $115 Million
719,435 Added 151.1%
1,195,581 $175 Million
Q4 2022

Feb 14, 2023

SELL
$129.72 - $159.85 $10.2 Million - $12.6 Million
-78,908 Reduced 14.22%
476,146 $75.9 Million
Q3 2022

Nov 14, 2022

SELL
$126.59 - $161.18 $20.9 Million - $26.6 Million
-165,076 Reduced 22.92%
555,054 $74 Million
Q2 2022

Aug 15, 2022

SELL
$141.59 - $168.66 $12.4 Million - $14.8 Million
-87,519 Reduced 10.84%
720,130 $112 Million
Q1 2022

May 16, 2022

BUY
$129.64 - $160.7 $47.6 Million - $59 Million
366,842 Added 83.22%
807,649 $126 Million
Q4 2021

Feb 14, 2022

BUY
$119.87 - $145.67 $52.8 Million - $64.2 Million
440,807 New
440,807 $56.2 Million
Q3 2021

Nov 15, 2021

SELL
$128.64 - $184.79 $3.37 Million - $4.85 Million
-26,229 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$160.2 - $186.42 $3.92 Million - $4.56 Million
24,460 Added 1382.7%
26,229 $4.66 Million
Q1 2021

May 17, 2021

SELL
$150.19 - $173.5 $17.4 Million - $20.1 Million
-115,938 Reduced 98.5%
1,769 $291,000
Q4 2020

Feb 16, 2021

SELL
$140.71 - $165.05 $19.3 Million - $22.6 Million
-137,105 Reduced 53.81%
117,707 $19.4 Million
Q3 2020

Nov 16, 2020

SELL
$105.46 - $144.13 $28.7 Million - $39.3 Million
-272,517 Reduced 51.68%
254,812 $36.3 Million
Q2 2020

Aug 14, 2020

BUY
$95.68 - $121.88 $46.1 Million - $58.7 Million
481,896 Added 1060.67%
527,329 $58.2 Million
Q1 2020

May 14, 2020

SELL
$87.74 - $152.74 $29,129 - $50,709
-332 Reduced 0.73%
45,433 $4.53 Million
Q4 2019

Feb 14, 2020

BUY
$117.65 - $153.73 $4.84 Million - $6.33 Million
41,157 Added 893.16%
45,765 $6.83 Million
Q3 2019

Nov 14, 2019

SELL
$125.18 - $143.24 $16.8 Million - $19.2 Million
-134,333 Reduced 96.68%
4,608 $590,000
Q2 2019

Aug 15, 2019

SELL
$125.55 - $144.48 $448 Million - $515 Million
-3,565,809 Reduced 96.25%
138,941 $19.8 Million
Q2 2019

Aug 14, 2019

BUY
$125.55 - $144.48 $449 Million - $517 Million
3,580,008 Added 2869.93%
3,704,750 $42.9 Million
Q1 2019

May 14, 2019

SELL
$121.81 - $142.95 $15.6 Million - $18.2 Million
-127,664 Reduced 50.58%
124,742 $17.8 Million
Q4 2018

Feb 14, 2019

BUY
$115.94 - $166.74 $16 Million - $23 Million
138,007 Added 120.64%
252,406 $31.3 Million
Q3 2018

Nov 14, 2018

BUY
$161.01 - $180.57 $18.4 Million - $20.7 Million
114,399 New
114,399 $19.2 Million
Q2 2018

Aug 14, 2018

SELL
$146.33 - $183.18 $32.3 Million - $40.4 Million
-220,639 Closed
0 $0
Q1 2018

May 15, 2018

BUY
$135.59 - $157.16 $26.2 Million - $30.4 Million
193,347 Added 708.44%
220,639 $33.3 Million
Q4 2017

Feb 14, 2018

SELL
$131.06 - $150.39 $13.5 Million - $15.5 Million
-103,198 Reduced 79.08%
27,292 $3.68 Million
Q3 2017

Nov 14, 2017

BUY
$142.62 - $155.6 $18.6 Million - $20.3 Million
130,490
130,490 $19.1 Million

Others Institutions Holding JAZZ

About Jazz Pharmaceuticals plc


  • Ticker JAZZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,680,700
  • Market Cap $7.94B
  • Description
  • Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...
More about JAZZ
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.